the ability of wy-18,251 to augment ts activity could be therapeutically useful in the treatment of those autoimmune diseases , such as rheumatoid arthritis and systemic lupus erythematosus , in which hyperactive b cell function is a characteristic feature .
C0004364
autoimmune diseases
C0024141
systemic lupus erythematosus